Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice-Reference-Cited by-同舟云学术

Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice

Published:2010-03 Issue:1 Volume:166 Page:40-48
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Mabrouk O.S.,Marti M.,Morari M.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference27 articles.

1. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression;Brown;J Neurochem,2006

2. [Nphe1,Arg14,Lys15]Nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor;Calò;Br J Pharmacol,2002

3. Disinhibition as a basic process in the expression of striatal functions;Deniau;Brain Res,1985

4. Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP(+) and 6-OHDA lesioned rats;Di Benedetto;Neuropharmacology,2009

5. Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice;Koizumi;J Neurochem,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?;International Journal of Molecular Sciences;2023-01-13

2. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders;International Journal of Molecular Sciences;2021-11-30

3. Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies;European Journal of Neuroscience;2021-04-25

4. Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease;Neuropharmacology;2020-05

5. Managing Parkinson's disease: moving ON with NOP;British Journal of Pharmacology;2020-01